Silence Therapeutics (SLN) Change in Cash (2020 - 2025)
Historic Change in Cash for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to $40.4 million.
- Silence Therapeutics' Change in Cash rose 17310.8% to $40.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 10864.76%. This contributed to the annual value of $52.5 million for FY2024, which is 286670.44% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Change in Cash is $40.4 million, which was up 17310.8% from -$23.3 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Change in Cash peaked at $74.0 million during Q1 2024, and registered a low of -$56.7 million during Q1 2025.
- For the 5-year period, Silence Therapeutics' Change in Cash averaged around $2.9 million, with its median value being -$1.9 million (2023).
- Within the past 5 years, the most significant YoY rise in Silence Therapeutics' Change in Cash was 1670649.72% (2022), while the steepest drop was 125310.96% (2022).
- Over the past 5 years, Silence Therapeutics' Change in Cash (Quarter) stood at $3.0 million in 2021, then crashed by 1253.11% to -$34.9 million in 2022, then soared by 94.44% to -$1.9 million in 2023, then skyrocketed by 2085.72% to $38.5 million in 2024, then increased by 4.8% to $40.4 million in 2025.
- Its last three reported values are $40.4 million in Q3 2025, -$23.3 million for Q2 2025, and -$56.7 million during Q1 2025.